...
首页> 外文期刊>European journal of gynaecological oncology >Secondary small cell carcinoma of the endometrium after concurrent chemoradiotherapy for cervical cancer: a rare case
【24h】

Secondary small cell carcinoma of the endometrium after concurrent chemoradiotherapy for cervical cancer: a rare case

机译:宫颈癌同时化疗后的子宫内膜的二次小细胞癌:罕见案例

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Small cell carcinoma of the endometrium is extremely rare. There is no reported case of secondary small cell carcinoma of the endometrium after concurrent chemoradiotherapy for cervical cancer. Case Report: A 48-year-old woman was diagnosed with squamous cell carcinoma of the cervix Stage IIIB (T3bN0M0) and treated by concurrent chemoradiotherapy. After five years and nine months' post-treatment, the woman was diagnosed with small cell carcinoma of the endometrium Stage IIIA (pT3aNXM0). Although the patient received chemotherapy combining paclitaxel and carboplatin postoperatively, she developed a recurrence with pelvic tumor three months after operation. After recurrence, she received one course of chemotherapy combining cisplatin and irinotecan. Although a remarkable reduction of recurrent tumor was found as autopsy findings, she died of disease two months after this chemotherapy. Conclusion: In case of small cell carcinoma of the endometrium, chemotherapy regimen used for small cell lung cancer such as chemotherapy combining cisplatin and irinotecan should be considered.
机译:背景:子宫内膜的小细胞癌极为罕见。宫颈癌同时化学疗法后,没有报告的子宫内膜的二次小细胞癌。案例报告:48岁的女性被诊断出患有子宫颈阶段IIIB(T3BN0M0)的鳞状细胞癌,并通过同时进行化学疗法治疗。经过五年,九个月后治疗后,妇女被诊断出患有子宫内膜阶段IIIa的小细胞癌(PT3ANXM0)。虽然患者术后接受了紫杉醇和卡铂的化疗,但她在手术后三个月与盆腔肿瘤发出复发。再次复发后,她接受了联铂和Irinotecan的一系列化疗。虽然发现复发性肿瘤的显着减少作为尸检调查结果,但她在此化疗后两个月死于疾病。结论:在小细胞癌的情况下,应考虑用于小细胞肺癌的化疗方案,例如Cisplatin和Irinotecan的化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号